Although the biological significance of polyP in the clinical outcome of human malignancies remains obscure, the identification of CD68+ polyP-expressing cells only in CRC sections and adenomas with high-grade dysplasia, but not in the non-malignant conditions of the colon, which was unexpected, could indicate the possibility of a novel prognostic biomarker. This evidence concerns the gene CD68 and adenoma.